In a study of pre-diabetic obese women with increased risk for EC, MET intake for 16 weeks produced no significant changes in serum IGF-I and insulin [44], suggesting that the changes in serum levels of these growth factors with MET may be a specific response of EC patients with full-blown diabetes. This evidence concerns the gene IGF1 and diabetes mellitus.